NOVELION THERAPEUTICS INC.

Other languages Novelion Therapeutics Inc. Toronto S.E.

Equities

NVLN

CA67001K2020

Delayed Toronto S.E. Other stock markets			5-day change	1st Jan Change
- ^CAD	-.--%		-2.92%	-.--%

2020	Novelion Therapeutics Inc. Announces Management Changes	CI
2020	Novelion Therapeutics Inc. Announces Management Changes	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Novelion Therapeutics Inc. Announces Final Cash Distribution, Payable on or About March 31, 2022	29/03/22
Novelion Therapeutics Inc. Provides the Earnings Guidance for the Year 2019	07/05/19
Novelion Therapeutics Inc. Provides Revenue Guidance for the Year 2019	14/03/19
Novelion Therapeutics Inc. Announces Unaudited Consolidated Financial Results for the Quarter and Six Months Ended June 30, 2018; Provides Revenue Guidance for the Year 2019	07/08/18
Novelion Therapeutics Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2017; Reiterates Revenue Guidance for the Full Year 2017	09/11/17
Novelion Therapeutics Inc. Announces Unaudited Consolidated Financial Results for the Quarter and Six Months Ended June 30, 2017; Revises Revenue Guidance for the Full Year of 2017	08/08/17
Novelion Therapeutics Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2017; Reiterates Revenue Guidance for the Year 2017	09/05/17
Novelion Therapeutics Inc. Revises Net Product Sales Guidance for the Year 2016; Provides Net Product Sales Guidance for the Year 2017	09/01/17

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW